Начало › Остра бифенотипна левкемия › Вашингтон
Клинични проучвания за Остра бифенотипна левкемия в Вашингтон
15 проучвания за Остра бифенотипна левкемия търсят участници в обекти в Вашингтон.
Градове в Вашингтон
Официален текст на проучването (английски)
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Fred Hutchinson Cancer Center, Seattle
Набиране на участнициФаза 1
Възраст от 12 до 78 · Всички полове · Обновено на 29.09.2026 г. · NCT03802695Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Набиране на участнициФаза 2
365 Days · Всички полове · Обновено на 25.09.2026 г. · NCT06317662CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Набиране на участнициФаза 1
Възраст 18 и повече · Всички полове · Обновено на 17.09.2026 г. · NCT04375631Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Набиране на участници
Възраст 18 и повече · Всички полове · Обновено на 17.09.2026 г. · NCT07094750Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
- Mary Bridge Children's Hospital and Health Center, Tacoma
Набиране на участнициФаза 3
365 Days – 25 Years · Всички полове · Обновено на 25.08.2026 г. · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
- Mary Bridge Children's Hospital and Health Center, Tacoma
- и още 1
Набиране на участнициФаза 1/2
До 22 години · Всички полове · Обновено на 25.08.2026 г. · NCT04726241Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Набиране на участнициФаза 2
6 Months – 65 Years · Всички полове · Обновено на 22.07.2026 г. · NCT06013423Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Набиране на участнициФаза 2
Възраст 18 и повече · Всички полове · Обновено на 20.07.2026 г. · NCT07046078211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Набиране на участнициФаза 1/2
Възраст от 18 до 75 · Всички полове · Обновено на 22.06.2026 г. · NCT03128034211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Набиране на участнициФаза 1/2
Възраст от 18 до 75 · Всички полове · Обновено на 22.06.2026 г. · NCT03670966Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Набиране на участнициФаза 2Здравите доброволци са добре дошли
6 Months · Всички полове · Обновено на 29.05.2026 г. · NCT04195633HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Набиране на участнициФаза 1
До 80 години · Всички полове · Обновено на 18.05.2026 г. · NCT03326921Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Набиране на участнициФаза 1/2Здравите доброволци са добре дошли
Възраст 18 и повече · Всички полове · Обновено на 15.05.2026 г. · NCT06928662Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Набиране на участнициФаза 1/2
Възраст 18 и повече · Всички полове · Обновено на 17.04.2026 г. · NCT04797767Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Seattle Children's Hospital, Seattle
Набиране на участнициФаза 1
Възраст от 1 до 21 · Всички полове · Обновено на 6.12.2024 г. · NCT05476770От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.